GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Administrative

$68,300
Steven D Leach · Johns Hopkins University · P01 · FY2010 · CA

Gastrointestinal Cancer (GIC)

$68,219
Jennifer D Black · University Of Nebraska Medical Center · P30 · FY2017 · CA

Cell Response and Regulation Program (Project-002)

$68,078
Douglas Grossman · University Of Utah · P30 · FY2017 · CA

Adoption and Retooling of GEM model for Pancreatic Cancer

$67,850
Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Comprehensive Cancer Center Core Support Grant

$67,828
Edward E Partridge · University Of Alabama At Birmingham · P30 · FY2007 · CA

CB: Pancreatic Tumor SPORE Tissue Bank

$67,795
Julia Bridge · University Of Nebraska Medical Center · P50 · FY2008 · CA

Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance

$67,758
Moran Amit · University Of Tx Md Anderson Can Ctr · R37 · FY2023 · CA

Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer

$67,758
Cullen Mitsuo Taniguchi · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Novel platforms for development of optimized genetically encoded fluorescent biosensors

$67,730
Dorothy Koveal · Harvard Medical School · F32 · FY2019 · GM

Metabolic Regulation of Pancreatic Epithelium Development

$67,582
Jeffrey Carl Davis · Massachusetts Institute Of Technology · F32 · FY2022 · HD

The Mitochondrial Calcium Uniporter in Pancreatic Cancer Development, Metastasis, and Treatment

$67,582
Jillian Weissenrieder · University Of Pennsylvania · F32 · FY2022 · CA

Precision Cancer Medicine and Investigational Therapeutics

$67,578
Scott J Antonia · Duke University · P30 · FY2023 · CA

Circulating tumor cells (CTCs) in EGFR-mutant human lung cancer

$67,534
Christina L Costantino · Massachusetts General Hospital · F32 · FY2018 · CA

The novel PRMT5-substrate adaptor interface provides a therapeutic target in MTAP null tumors

$67,446
Kathleen Mulvaney · Broad Institute, Inc. · F32 · FY2020 · CA

Genetic alterations of KLF4 in human pancreatic cancer

$67,290
Daoyan Wei · University Of Tx Md Anderson Can Ctr · R03 · FY2007 · CA

Precision Cancer Medicine and Investigational Therapeutics

$67,206
Scott J Antonia · Duke University · P30 · FY2022 · CA

Understanding tumorigenesis and metastasis of pancreatic cancer through precision whole-body imaging of senescence with ImmunoPET

$67,174
Edwin Charles Pratt · Sloan-Kettering Inst Can Research · F32 · FY2022 · CA

The Role of eIF4G1 and eIF4G2 in Translational Control of Adipogenesis and Obesity

$67,174
Rachel Elizabeth Turn · Stanford University · F32 · FY2022 · GM

Giant Macrophage-like Cells as a blood-based Biomarker for Lung Cancer Recurrence

$67,150
Daniel L. Adams · Creatv Microtech, Inc. · R43 · FY2018 · CA

Developmental Research Program

$67,077
Michael G Brattain · University Of Nebraska Medical Center · P50 · FY2010 · CA

Population Sciences

$66,651
Esther M John · Stanford University · P30 · FY2022 · CA

Administrative

$66,543
Steven D Leach · Johns Hopkins University · P01 · FY2011 · CA

Career Enhancement Program

$66,521
Christine A Iacobuzio-Donahue · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA

Elucidating the molecular mechanisms of PRMT5i response and resistance in LUAD and PDAC

$66,390
Pedro Nicolas Pozo · Massachusetts Institute Of Technology · F32 · FY2021 · CA

Elucidating the role of SHOC2 to enhance MEK inhibitor sensitivity in pancreatic cancer

$66,390
Jason Kwon · Dana-Farber Cancer Inst · F32 · FY2021 · CA